Latest OrbusNeich Stories
Registration study to enroll 572 patients at up to 50 study locations in Japan and US HONG KONG, May 18, 2015 /PRNewswire/ -- OrbusNeich, a global company specializing
DALLAS, November 28, 2014 /PRNewswire/ -- MarketReportsOnline.com offers Medical Device Pricing & Reimbursement 2014 market research guide that provides insights into
DALLAS, November 26, 2014 /PRNewswire/ -- The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative
WASHINGTON, September 18, 2014 /PRNewswire/ -- The world's first and only dual therapy stent Prof. Stephen W.L.
ZWOLLE, The Netherlands, June 12, 2014 /PRNewswire/ -- Randomized Evaluation of short-term DUal antiplatelet therapy in patients with acute coronary syndrome treated with
COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ --
HONG KONG, April 24, 2014 /PRNewswire/ -- OrbusNeich today announced the appointment of B.
DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/znsx2b/global_and ) has announced the addition of the "Global and
Post-Market Registry to Evaluate Long-Term Safety and Performance in Routine Practice HONG KONG, March 28, 2014 /PRNewswire/ -- OrbusNeich today announced the completion of enrollment
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.